Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome

Journal of Psychiatric Research

Volumn 31, Issue 1, 1997, Pages 149-156

  Gupta, Sudhir ^a,b   Aggarwal, Sudeepta ^a   See, Darryl ^a   Starr, Arnold ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CELL ADHESION; CELL STIMULATION; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MONOCYTE; MONONUCLEAR CELL; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUPERNATANT;

ADULT; BASE SEQUENCE; CYTOKINES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0030969176     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(96)00063-5     Document Type: Conference Paper

References (30)

1. Moutschen, M., Triffaux, J. M., Demonty, J., Legros, J. J., & Lefebvre, P. J. (1994). Pathogenic tracks in fatigue syndrome. Acta Clinica Belgica, 49, 247-289.
2. Levy, J. A. (1994). Viral studies of chronic fatigue syndrome. Clin. Infect. Dis., 18(suppl 1), S117-S120.
3. Demitrack, M. A., Dale, J. K., Straus, S. E., Laue, L., Listwak, S. J., Kruesi, M. J., Chrousos, G. P., & Gold, P. W. (1991). Evidence of impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocr. Metabol., 73, 1224-1234.
4. Dinarello, C. A. (1988). Biology of interleukin-1. FASEB J., 2, 108-115.
5. Gupta, S. (1988). Cytokines: molecular and biological characteristics. Scand. J.Rheumatol., S76, 189-201.
6. Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1990). Interleukin-6 family of cytokines and gp130. Blood, 86, 1243-1254.
7. Buchwald, D., & Komaroff, A. L. (1991). Review of laboratory findings for patients with chronic fatigue syndrome. Rev. Infect. Dis., 13(suppl.1), S12-S18.
8. Gupta, S., & Vayuvegula, B. (1991). A comprehensive immunological analysis in chronic fatigue syndrome. Scand. J. Immunol., 33, 319-327.
9. Gupta, S. (1992) Recent developments in immunological aspects of chronic fatigue syndrome. In The clinical and scientific basis of myalgic encephalomyelitis chronic fatigue syndrome (pp. 545-550). New York: The Nightingale Research Foundation.
10. Jone, J. F. (1991). Serologic and immunologic responses in chronic fatigue syndrome with emphasis on the Epstein-Barr virus. Rev. Infect. Dis., 1, S26-S31.
11. Kalimas, N. G., Salvato, F. R., Morgan, R., & Fletcher, M. A. (1990). Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol., 28, 1403-1410.
12. Lloyd, A. R., Wakefield, D., Dwyer, J., & Boughton, C. (1989). Immunological abnormalities in the chronic fatigue syndrome. Med. J. Aust., 151, 122-124.
13. Straus, S. E., Fritz, S., Dale, J. K., Gould, B., & Strober, W. (1993). Lymphocyte phenotype and function in the chronic fatigue syndrome. J. Clin. Immunol., 13, 30-40.
14. Cheney, P. R., Dorman, S. E., & Bell, D. S. (1989). Interleukin-2 and the chronic fatigue syndrome. Ann. Int. Med., 110, 321.
15. Lever, A. M. L., Lewis, D. M., Bannister, B. A., & Fry, M., Berry, N. (1988). Interferon production in post-viral fatigue syndrome. Lancet, 2, 101.
16. Straus, S. E., Dale, J. K., Peter, J. B., & Dinarello, C. A. (1989). Circulating lymphokine levels in the chronic fatigue syndrome. J. Infect. Dis., 160, 1085-1086.
17. Lloyd, A., Gandevia, S., Brockman, A., Hales, J., & Wakefield, D. (1994). Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise. Clin. Infect. Dis., 18(suppl 1, S142-146.
18. Linde, A., Andersson, B., Svenson, S. B., Ahrne, H., Carlsson, M., Forsberg, P., Hugo, H., Karstorp, A., Lenkei, R., Lindwall, A., Loftenius, A., Salb, C., & Andersson, J. (1992). Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J. Infect. Dis., 330, 858-859.
19. Chao, C. C., Janoff, E. N., Hu, S., Thomas, K., Gallagher, M., Tsang, M., & Peterson, P. K. (1991). Altered cytokine release in peripheral blood mononuclear cell cultures from patients with chronic fatigue syndrome. Cytokine, 3, 292-298.
20. Gold, D., Bowden, R., Sixbey, J., Riggs, R., Katon, W. J., Ashley, R., Obrigervitch, R., & Corey, L. (1990). Chronic fatigue: a prospective clinical and virologie study. JAMA, 264, 48-53.
21. Milton, J. D., Clements, G. B., & Edwards, R. H. (1991). Immune responsiveness in chronic fatigue syndrome. Postgrad. Med. J., 67, 532-537.
22. Morte, S., Castilla, A., Civeira, M. -P., Serrano, M., & Prieto, J. (1988). Gamma-interferon and chronic fatigue syndrome. Lancet, 2, 623-624.
23. Altmann, C., Larratt, K., Golubjatnikov, R., Kirmani, N., & Rytel, M. (1988). Immunologic markers in the chronic fatigue syndrome. Clin. Res., 36, 845A.
24. Rasmussen, A. K., Noelsen, H., Andersen, V., Barington, T., Bendtzen, K., Hansen, M. B., Nielsen, L., Pedersen, B. K., & Wiik, A. (1991). Chronic fatigue syndrome-a controlled cross sectional study. J. Rheumatol., 21, 1527-1531.
25. Chao, C. C., Gallagher, M., Phair, J., & Peterson, P. K. (1991). Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J. Infect. Dis., 162, 1412-1413.
26. Patarca, R., Kalimas, N. G., Lutendorf, S., Antoni, M., Fletcher, M. A. (1991). Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin. Infect. Dis., 18(suppl 1, S147-S153.
27. Matsuyama, T., Kobayashi, N., & Yamamoto, N. (1991). Cykotines HIV infection: is AIDS a tumor necrosis factor disease? AIDS, 5, 1405-1417.
28. Brosnan, C. F., Selmaj, K., & Raines, C. S. (1988). Hypothesis: a role of tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J. Neuroimmunol., 18, 87-94.
29. Howard, M., O'Garra, A., Ishida, H., de Waal Malefyt, R., & de Vries, J. (1992). Biological properties of 1L-10. J. Clin. Immunol., 12, 239-247.
30. Fiorentino, D. F., Zlotnik, A., Mossman, T. R., Howard, M., & O'Garra, A. (1991). IL-10 inhibits cytokines produced by activated macrophages. J. Immunol., 147, 3815-3822.